<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>AssayData_RNA_data_all_monocytes_all_sample_collapsed_to_symbols.Class_all_monocytes_all_sample_with_header.cls<br>#1_versus_0.Class_all_monocytes_all_sample_with_header.cls<br>#1_versus_0_repos</td></tr><tr><td>Phenotype</td><td>Class_all_monocytes_all_sample_with_header.cls#1_versus_0_repos</td></tr><tr><td>Upregulated in class</td><td>0</td></tr><tr><td>GeneSet</td><td>WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE</td></tr><tr><td>Enrichment Score (ES)</td><td>-0.6796506</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>-1.976058</td></tr><tr><td>Nominal p-value</td><td>0.0</td></tr><tr><td>FDR q-value</td><td>0.00518844</td></tr><tr><td>FWER p-Value</td><td>0.06</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE' src='enplot_WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE_447.png'><br><br><caption>Fig 1: Enrichment plot: WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='7' border='1'><th class='richTable'></th><th class='richTable'>SYMBOL</th><th class='richTable'>TITLE</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://ensembl.org/Search/Results?q=NFATC3'>NFATC3</a></td><td>NFATC3</td><td>527</td><td>0.098</td><td>0.0683</td><td>No</td></tr><tr><td class='lessen'>2</td><td><a href='https://ensembl.org/Search/Results?q=NFAT5'>NFAT5</a></td><td>NFAT5</td><td>1700</td><td>0.051</td><td>0.0594</td><td>No</td></tr><tr><td class='lessen'>3</td><td><a href='https://ensembl.org/Search/Results?q=NFATC2'>NFATC2</a></td><td>NFATC2</td><td>3642</td><td>0.028</td><td>-0.0108</td><td>No</td></tr><tr><td class='lessen'>4</td><td><a href='https://ensembl.org/Search/Results?q=NFKB1'>NFKB1</a></td><td>NFKB1</td><td>4300</td><td>0.023</td><td>-0.0215</td><td>No</td></tr><tr><td class='lessen'>5</td><td><a href='https://ensembl.org/Search/Results?q=NFATC1'>NFATC1</a></td><td>NFATC1</td><td>4698</td><td>0.020</td><td>-0.0216</td><td>No</td></tr><tr><td class='lessen'>6</td><td><a href='https://ensembl.org/Search/Results?q=BATF'>BATF</a></td><td>BATF</td><td>5080</td><td>0.018</td><td>-0.0231</td><td>No</td></tr><tr><td class='lessen'>7</td><td><a href='https://ensembl.org/Search/Results?q=CD274'>CD274</a></td><td>CD274</td><td>5366</td><td>0.017</td><td>-0.0211</td><td>No</td></tr><tr><td class='lessen'>8</td><td><a href='https://ensembl.org/Search/Results?q=IFNG'>IFNG</a></td><td>IFNG</td><td>8240</td><td>0.007</td><td>-0.1580</td><td>No</td></tr><tr><td class='lessen'>9</td><td><a href='https://ensembl.org/Search/Results?q=PDCD1'>PDCD1</a></td><td>PDCD1</td><td>9025</td><td>0.005</td><td>-0.1926</td><td>No</td></tr><tr><td class='lessen'>10</td><td><a href='https://ensembl.org/Search/Results?q=NFATC4'>NFATC4</a></td><td>NFATC4</td><td>12919</td><td>-0.001</td><td>-0.3864</td><td>No</td></tr><tr><td class='lessen'>11</td><td><a href='https://ensembl.org/Search/Results?q=CD8A'>CD8A</a></td><td>CD8A</td><td>13050</td><td>-0.001</td><td>-0.3919</td><td>No</td></tr><tr><td class='lessen'>12</td><td><a href='https://ensembl.org/Search/Results?q=CD8B'>CD8B</a></td><td>CD8B</td><td>13285</td><td>-0.001</td><td>-0.4022</td><td>No</td></tr><tr><td class='lessen'>13</td><td><a href='https://ensembl.org/Search/Results?q=ZAP70'>ZAP70</a></td><td>ZAP70</td><td>13327</td><td>-0.002</td><td>-0.4028</td><td>No</td></tr><tr><td class='lessen'>14</td><td><a href='https://ensembl.org/Search/Results?q=LCK'>LCK</a></td><td>LCK</td><td>13711</td><td>-0.002</td><td>-0.4196</td><td>No</td></tr><tr><td class='lessen'>15</td><td><a href='https://ensembl.org/Search/Results?q=PTPN11'>PTPN11</a></td><td>PTPN11</td><td>15514</td><td>-0.008</td><td>-0.5020</td><td>No</td></tr><tr><td class='lessen'>16</td><td><a href='https://ensembl.org/Search/Results?q=CD3E'>CD3E</a></td><td>CD3E</td><td>16186</td><td>-0.011</td><td>-0.5251</td><td>No</td></tr><tr><td class='lessen'>17</td><td><a href='https://ensembl.org/Search/Results?q=STAT3'>STAT3</a></td><td>STAT3</td><td>16923</td><td>-0.015</td><td>-0.5476</td><td>No</td></tr><tr><td class='lessen'>18</td><td><a href='https://ensembl.org/Search/Results?q=PDCD1LG2'>PDCD1LG2</a></td><td>PDCD1LG2</td><td>19567</td><td>-0.083</td><td>-0.5987</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>19</td><td><a href='https://ensembl.org/Search/Results?q=CD3G'>CD3G</a></td><td>CD3G</td><td>19577</td><td>-0.084</td><td>-0.5174</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>20</td><td><a href='https://ensembl.org/Search/Results?q=JUN'>JUN</a></td><td>JUN</td><td>19680</td><td>-0.099</td><td>-0.4260</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>21</td><td><a href='https://ensembl.org/Search/Results?q=CD3D'>CD3D</a></td><td>CD3D</td><td>19725</td><td>-0.108</td><td>-0.3235</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>22</td><td><a href='https://ensembl.org/Search/Results?q=HLA-A'>HLA-A</a></td><td>HLA-A</td><td>19903</td><td>-0.163</td><td>-0.1740</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>23</td><td><a href='https://ensembl.org/Search/Results?q=HLA-DRB1'>HLA-DRB1</a></td><td>HLA-DRB1</td><td>19939</td><td>-0.186</td><td>0.0047</td><td bgcolor='#CCFFCC'>Yes</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE.tsv'>[plain text format]</a></caption></table></div><br><div class='image'><img name='WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE' src='WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE_448.png'><br><br><caption>Fig 2: WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE &nbsp&nbsp <br> Blue-Pink O' Gram in the Space of the Analyzed GeneSet</caption></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_449.png'><br><br><caption>Fig 3: WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE</b></caption></div><br></body></html>